Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study.

Marie-Claire C, Courtin C, Curis E, Bouaziz-Amar E, Laplanche JL, Jacob A, Etain B, Blanchard A, Bellivier F.

J Neuroimmunol. 2019 Sep 15;334:576993. doi: 10.1016/j.jneuroim.2019.576993. Epub 2019 Jun 7.

PMID:
31203140
2.

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

Cognat E, Mouton Liger F, Troussière AC, Wallon D, Dumurgier J, Magnin E, Duron E, Gabelle A, Croisile B, de la Sayette V, Jager A, Blanc F, Bouaziz-Amar E, Miguet-Alfonsi C, Quillard M, Schraen S, Philippi N, Beaufils E, Pasquier F, Hannequin D, Robert P, Hugon J, Paquet C; ePLM network.

BMJ Open. 2019 May 30;9(5):e026380. doi: 10.1136/bmjopen-2018-026380.

3.

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

Lafirdeen ASM, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J.

PLoS One. 2019 May 14;14(5):e0217026. doi: 10.1371/journal.pone.0217026. eCollection 2019.

4.

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.

Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M, Bousiges O, Delaby C, Dumurgier J, Hugon J, Sablonnière B, Blanc F, Wallon D, Gabelle A, Laplanche JL, Bouaziz-Amar E, Peoc'h K; ePLM Group.

Clin Chim Acta. 2019 Aug;495:451-456. doi: 10.1016/j.cca.2019.04.081. Epub 2019 Apr 30.

PMID:
31051163
5.

CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease.

Boumenir A, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J.

Alzheimers Res Ther. 2019 Mar 28;11(1):29. doi: 10.1186/s13195-019-0481-4.

6.

Frontotemporal dementia is the leading cause of "true" A-/T+ profiles defined with Aβ42/40 ratio.

Pouclet-Courtemanche H, Nguyen TB, Skrobala E, Boutoleau-Bretonnière C, Pasquier F, Bouaziz-Amar E, Bigot-Corbel E, Schraen S, Dumurgier J, Paquet C, Lebouvier T.

Alzheimers Dement (Amst). 2019 Feb 15;11:161-169. doi: 10.1016/j.dadm.2019.01.001. eCollection 2019 Dec.

7.

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease.

Öhrfelt A, Brinkmalm A, Dumurgier J, Zetterberg H, Bouaziz-Amar E, Hugon J, Paquet C, Blennow K.

Neuroscience. 2019 Nov 10;420:136-144. doi: 10.1016/j.neuroscience.2018.11.038. Epub 2018 Dec 5.

8.

First European case of Creutzfeldt-Jakob disease with a PRNP G114V mutation.

Cousyn L, Grabli D, Seilhean D, Azuar C, Huiban C, Epelbaum S, Bouaziz-Amar E, Brandel JP, Galanaud D, Méneret A.

Cortex. 2019 Aug;117:407-413. doi: 10.1016/j.cortex.2018.08.014. Epub 2018 Sep 1.

PMID:
30266397
9.

Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.

Paquet C, Bouaziz-Amar E, Cognat E, Volpe-Gillot L, Haddad V, Mahieux F, Dekimeche S, Defontaines B, Chabriat H, Belin C, Texeira A, Goutagny S, Questel F, Azuar J, Sellier PO, Laplanche JL, Hugon J, Dumurgier J.

J Alzheimers Dis. 2018;64(3):889-897. doi: 10.3233/JAD-180240.

PMID:
29966201
10.

Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.

Poitou C, Bouaziz-Amar E, Genser L, Oppert JM, Lacorte JM, Le Beyec J.

Surg Obes Relat Dis. 2018 Jul;14(7):929-935. doi: 10.1016/j.soard.2018.03.014. Epub 2018 Mar 19.

PMID:
29703503
11.

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers.

Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc H K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen S, Pasquier F, Bombois S, For The E-Plm Group.

Curr Alzheimer Res. 2018;15(7):691-700. doi: 10.2174/1567205015666180110113238.

PMID:
29318973
12.

Vitamin D Status, Insulin Resistance, Leptin-To-Adiponectin Ratio in Adolescents: Results of a 1-Year Lifestyle Intervention.

Rambhojan C, Larifla L, Clepier J, Bouaziz-Amar E, Velayoudom-Cephise FL, Blanchet-Deverly A, Armand C, Plumasseau J, Lacorte JM, Foucan L.

Open Access Maced J Med Sci. 2016 Dec 15;4(4):596-602. doi: 10.3889/oamjms.2016.131. Epub 2016 Dec 8.

13.

[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases].

Magnin E, Dumurgier J, Bouaziz-Amar E, Bombois S, Wallon D, Gabelle A, Lehmann S, Blanc F, Bousiges O, Hannequin D, Jung B, Miguet-Alfonsi C, Quillard M, Pasquier F, Peoc'h K, Laplanche JL, Hugon J, Paquet C; pour le groupe ePLM (étude des biomarqueurs de la Ponction Lombaire Multicentrique).

Rev Med Interne. 2017 Apr;38(4):250-255. doi: 10.1016/j.revmed.2016.10.383. Epub 2016 Nov 24. Review. French.

PMID:
27890382
14.

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.

Öhrfelt A, Brinkmalm A, Dumurgier J, Brinkmalm G, Hansson O, Zetterberg H, Bouaziz-Amar E, Hugon J, Paquet C, Blennow K.

Alzheimers Res Ther. 2016 Oct 3;8(1):41.

15.

Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study.

Paquet C, Magnin E, Wallon D, Troussière AC, Dumurgier J, Jager A, Bellivier F, Bouaziz-Amar E, Blanc F, Beaufils E, Miguet-Alfonsi C, Quillard M, Schraen S, Pasquier F, Hannequin D, Robert P, Hugon J, Mouton-Liger F; For ePLM network and collaborators.

Alzheimers Res Ther. 2016 Jun 13;8:27. doi: 10.1186/s13195-016-0192-z.

16.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

17.

Ghrelin, adipokines, metabolic factors in relation with weight status in school-children and results of a 1-year lifestyle intervention program.

Rambhojan C, Bouaziz-Amar E, Larifla L, Deloumeaux J, Clepier J, Plumasseau J, Lacorte JM, Foucan L.

Nutr Metab (Lond). 2015 Nov 14;12:43. doi: 10.1186/s12986-015-0039-9. eCollection 2015.

Supplemental Content

Loading ...
Support Center